At what age do bronchodilator drugs work?

Area of Science:

• Pediatric Pulmonology
• Respiratory Physiology
• Pharmacology

Background:

• Wheezing in young children is a common respiratory issue.
• Bronchodilator therapy, like salbutamol, is often used to manage wheezing.
• Understanding the age-related response to bronchodilators is crucial for effective treatment.

Purpose of the Study:

• To assess the efficacy of nebulized salbutamol in reducing respiratory resistance in wheezing infants and young children.
• To investigate age-dependent differences in response to salbutamol therapy.
• To evaluate changes in thoracic gas volume following salbutamol administration.

Main Methods:

• A modified forced oscillation technique was employed to measure respiratory resistance.
• Respiratory resistance was measured before and after nebulized salbutamol administration.
• A subset of children underwent total body plethysmography to assess thoracic gas volume.

Main Results:

• Children over 20 months of age demonstrated a significant decrease in respiratory resistance (>20%) post-salbutamol.
• In contrast, children under 18 months showed minimal improvement in respiratory resistance (<5%).
• No significant changes in thoracic gas volume were observed in infants under 18 months.

Conclusions:

• Nebulized salbutamol is effective in improving respiratory resistance in wheezing children over 20 months old.
• Younger infants (under 18 months) exhibit a limited response to salbutamol, suggesting different underlying pathophysiology or airway receptor development.
• Age is a critical factor in determining the therapeutic response to salbutamol in pediatric wheezing.